Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2014

Open Access 01-12-2014 | Research

Critical role of TNF-α in cerebral aneurysm formation and progression to rupture

Authors: Robert M Starke, Nohra Chalouhi, Pascal M Jabbour, Stavropoula I Tjoumakaris, L Fernando Gonzalez, Robert H Rosenwasser, Kosuke Wada, Kenji Shimada, David M Hasan, Nigel H Greig, Gary K Owens, Aaron S Dumont

Published in: Journal of Neuroinflammation | Issue 1/2014

Login to get access

Abstract

Background

Alterations in TNF-α expression have been associated with cerebral aneurysms, but a direct role in formation, progression, and rupture has not been established.

Methods

Cerebral aneurysms were induced through hypertension and a single stereotactic injection of elastase into the basal cistern in mice. To test the role of TNF-α in aneurysm formation, aneurysms were induced in TNF-α knockout mice and mice pretreated with the synthesized TNF-α inhibitor 3,6′dithiothalidomide (DTH). To assess the role of TNF-α in aneurysm progression and rupture, DTH was started 6 days after aneurysm induction. TNF-α expression was assessed through real-time PCR and immunofluorescence staining.

Results

TNF-α knockout mice and those pre-treated with DTH had significantly decreased incidence of aneurysm formation and rupture as compared to sham mice. As compared with sham mice, TNF-α protein and mRNA expression was not significantly different in TNF-α knockout mice or those pre-treated with DTH, but was elevated in unruptured and furthermore in ruptured aneurysms. Subarachnoid hemorrhage (SAH) occurred between 7 and 21 days following aneurysm induction. To ensure aneurysm formation preceded rupture, additional mice underwent induction and sacrifice after 7 days. Seventy-five percent had aneurysm formation without evidence of SAH. Initiation of DTH treatment 6 days after aneurysm induction did not alter the incidence of aneurysm formation, but resulted in aneurysmal stabilization and a significant decrease in rupture.

Conclusions

These data suggest a critical role of TNF-α in the formation and rupture of aneurysms in a model of cerebral aneurysm formation. Inhibitors of TNF-α could be beneficial in preventing aneurysmal progression and rupture.
Appendix
Available only for authorised users
Literature
1.
go back to reference Molyneux AJ, Kerr RS, Birks J, Ramzi N, Yarnold J, Sneade M, Rischmiller J: Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol. 2009, 8: 427-433. 10.1016/S1474-4422(09)70080-8.PubMedCentralCrossRefPubMed Molyneux AJ, Kerr RS, Birks J, Ramzi N, Yarnold J, Sneade M, Rischmiller J: Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol. 2009, 8: 427-433. 10.1016/S1474-4422(09)70080-8.PubMedCentralCrossRefPubMed
2.
go back to reference Wiebers DO, Whisnant JP, Huston J, Meissner I, Brown RD, Piepgras DG, Forbes GS, Thielen K, Nichols D, O’Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC, International Study of Unruptured Intracranial Aneurysms Investigators: Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003, 362: 103-110. 10.1016/S0140-6736(03)13860-3.CrossRefPubMed Wiebers DO, Whisnant JP, Huston J, Meissner I, Brown RD, Piepgras DG, Forbes GS, Thielen K, Nichols D, O’Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC, International Study of Unruptured Intracranial Aneurysms Investigators: Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003, 362: 103-110. 10.1016/S0140-6736(03)13860-3.CrossRefPubMed
3.
go back to reference Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, Hashimoto N, Nakayama T, Sakai M, Teramoto A, Tominari S, Yoshimoto T: The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012, 366: 2474-2482.CrossRefPubMed Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, Hashimoto N, Nakayama T, Sakai M, Teramoto A, Tominari S, Yoshimoto T: The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012, 366: 2474-2482.CrossRefPubMed
4.
go back to reference Chalouhi N, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Koch WJ, Dumont AS: Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab. 2012, 32: 1659-1676. 10.1038/jcbfm.2012.84.PubMedCentralCrossRefPubMed Chalouhi N, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Koch WJ, Dumont AS: Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab. 2012, 32: 1659-1676. 10.1038/jcbfm.2012.84.PubMedCentralCrossRefPubMed
5.
go back to reference Jayaraman T, Berenstein V, Li X, Mayer J, Silane M, Shin YS, Niimi Y, Kilic T, Gunel M, Berenstein A: Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery. 2005, 57: 558-564. 10.1227/01.NEU.0000170439.89041.D6. discussion 558–564CrossRefPubMed Jayaraman T, Berenstein V, Li X, Mayer J, Silane M, Shin YS, Niimi Y, Kilic T, Gunel M, Berenstein A: Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery. 2005, 57: 558-564. 10.1227/01.NEU.0000170439.89041.D6. discussion 558–564CrossRefPubMed
6.
go back to reference Jayaraman T, Paget A, Shin YS, Li X, Mayer J, Chaudhry H, Niimi Y, Silane M, Berenstein A: TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag. 2008, 4: 805-817.PubMedCentralPubMed Jayaraman T, Paget A, Shin YS, Li X, Mayer J, Chaudhry H, Niimi Y, Silane M, Berenstein A: TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag. 2008, 4: 805-817.PubMedCentralPubMed
7.
go back to reference Kleinbongard P, Heusch G, Schulz R: TNF alpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther. 2010, 127: 295-314. 10.1016/j.pharmthera.2010.05.002.CrossRefPubMed Kleinbongard P, Heusch G, Schulz R: TNF alpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther. 2010, 127: 295-314. 10.1016/j.pharmthera.2010.05.002.CrossRefPubMed
8.
go back to reference Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Owens GK, Koch WJ, Greig NH, Dumont AS: TNF-alpha induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology. J Cereb Blood Flow Metab. 2013, 33: 1564-1573. 10.1038/jcbfm.2013.109.PubMedCentralCrossRefPubMed Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Owens GK, Koch WJ, Greig NH, Dumont AS: TNF-alpha induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology. J Cereb Blood Flow Metab. 2013, 33: 1564-1573. 10.1038/jcbfm.2013.109.PubMedCentralCrossRefPubMed
9.
go back to reference Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van Rooijen N, Lawton MT, Young WL, Liang EI, Nuki Y, Hashimoto T: Critical roles of macrophages in the formation of intracranial aneurysm. Stroke. 2011, 42: 173-178. 10.1161/STROKEAHA.110.590976.PubMedCentralCrossRefPubMed Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van Rooijen N, Lawton MT, Young WL, Liang EI, Nuki Y, Hashimoto T: Critical roles of macrophages in the formation of intracranial aneurysm. Stroke. 2011, 42: 173-178. 10.1161/STROKEAHA.110.590976.PubMedCentralCrossRefPubMed
10.
go back to reference Tedgui A, Mallat Z: Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006, 86: 515-581. 10.1152/physrev.00024.2005.CrossRefPubMed Tedgui A, Mallat Z: Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006, 86: 515-581. 10.1152/physrev.00024.2005.CrossRefPubMed
11.
go back to reference Hara A, Yoshimi N, Mori H: Evidence for apoptosis in human intracranial aneurysms. Neurol Res. 1998, 20: 127-130.PubMed Hara A, Yoshimi N, Mori H: Evidence for apoptosis in human intracranial aneurysms. Neurol Res. 1998, 20: 127-130.PubMed
12.
go back to reference National Research Counci: Guide for the Care and Use of Laboratory Animals: Eighth Edition. 2011, Washington, DC: The National Academies Press National Research Counci: Guide for the Care and Use of Laboratory Animals: Eighth Edition. 2011, Washington, DC: The National Academies Press
13.
go back to reference Nuki Y, Tsou TL, Kurihara C, Kanematsu M, Kanematsu Y, Hashimoto T: Elastase-induced intracranial aneurysms in hypertensive mice. Hypertension. 2009, 54: 1337-1344. 10.1161/HYPERTENSIONAHA.109.138297.PubMedCentralCrossRefPubMed Nuki Y, Tsou TL, Kurihara C, Kanematsu M, Kanematsu Y, Hashimoto T: Elastase-induced intracranial aneurysms in hypertensive mice. Hypertension. 2009, 54: 1337-1344. 10.1161/HYPERTENSIONAHA.109.138297.PubMedCentralCrossRefPubMed
14.
go back to reference Makino H, Tada Y, Wada K, Liang EI, Chang M, Mobashery S, Kanematsu Y, Kurihara C, Palova E, Kanematsu M, Kitazato K, Hashimoto T: Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke. 2012, 43: 2450-2456. 10.1161/STROKEAHA.112.659821.PubMedCentralCrossRefPubMed Makino H, Tada Y, Wada K, Liang EI, Chang M, Mobashery S, Kanematsu Y, Kurihara C, Palova E, Kanematsu M, Kitazato K, Hashimoto T: Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke. 2012, 43: 2450-2456. 10.1161/STROKEAHA.112.659821.PubMedCentralCrossRefPubMed
15.
go back to reference Weiss D, Taylor WR: Deoxycorticosterone acetate salt hypertension in apolipoprotein E−/−mice results in accelerated atherosclerosis: the role of angiotensin II. Hypertension. 2008, 51: 218-224. 10.1161/HYPERTENSIONAHA.107.095885.CrossRefPubMed Weiss D, Taylor WR: Deoxycorticosterone acetate salt hypertension in apolipoprotein E−/−mice results in accelerated atherosclerosis: the role of angiotensin II. Hypertension. 2008, 51: 218-224. 10.1161/HYPERTENSIONAHA.107.095885.CrossRefPubMed
16.
go back to reference Nagata I, Handa H, Hashimoto N, Hazama F: Experimentally induced cerebral aneurysms in rats: part VI. Hypertension. Surg Neurol. 1980, 14: 477-479.PubMed Nagata I, Handa H, Hashimoto N, Hazama F: Experimentally induced cerebral aneurysms in rats: part VI. Hypertension. Surg Neurol. 1980, 14: 477-479.PubMed
17.
go back to reference Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994, 265: 1883-1885. 10.1126/science.7522345.CrossRefPubMed Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994, 265: 1883-1885. 10.1126/science.7522345.CrossRefPubMed
18.
go back to reference Jeon H, Ai J, Sabri M, Tariq A, Shang X, Chen G, Macdonald RL: Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci. 2009, 10: 103-10.1186/1471-2202-10-103.PubMedCentralCrossRefPubMed Jeon H, Ai J, Sabri M, Tariq A, Shang X, Chen G, Macdonald RL: Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci. 2009, 10: 103-10.1186/1471-2202-10-103.PubMedCentralCrossRefPubMed
19.
go back to reference Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H: Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 1994, 25: 165-170. 10.1161/01.STR.25.1.165.CrossRefPubMed Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H: Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 1994, 25: 165-170. 10.1161/01.STR.25.1.165.CrossRefPubMed
20.
go back to reference Jankowski M, Rachelska G, Donghao W, McCann SM, Gutkowska J: Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc Natl Acad Sci U S A. 2001, 98: 11765-11770. 10.1073/pnas.201394198.PubMedCentralCrossRefPubMed Jankowski M, Rachelska G, Donghao W, McCann SM, Gutkowska J: Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc Natl Acad Sci U S A. 2001, 98: 11765-11770. 10.1073/pnas.201394198.PubMedCentralCrossRefPubMed
21.
go back to reference Luo WM, Yu QS, Tweedie D, Deschamps J, Parrish D, Holloway HW, Li YZ, Brossi A, Greig NH: Synthesis of aromatic substituted 6'-thaiothalidomides. Synthesis. 2008, 2008: 3415-3422. 10.1055/s-0028-1083179.CrossRef Luo WM, Yu QS, Tweedie D, Deschamps J, Parrish D, Holloway HW, Li YZ, Brossi A, Greig NH: Synthesis of aromatic substituted 6'-thaiothalidomides. Synthesis. 2008, 2008: 3415-3422. 10.1055/s-0028-1083179.CrossRef
22.
go back to reference Belarbi K, Jopson T, Tweedie D, Arellano C, Luo W, Greig NH, Rosi S: TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflammation. 2012, 9: 23-10.1186/1742-2094-9-23.PubMedCentralCrossRefPubMed Belarbi K, Jopson T, Tweedie D, Arellano C, Luo W, Greig NH, Rosi S: TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflammation. 2012, 9: 23-10.1186/1742-2094-9-23.PubMedCentralCrossRefPubMed
23.
go back to reference Starke RM, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez F, Hasan DM, Rosenwasser RH, Owens GK, Koch WJ, Dumont AS: Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. PLoS One. 2013, 8: e71954-10.1371/journal.pone.0071954.PubMedCentralCrossRefPubMed Starke RM, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez F, Hasan DM, Rosenwasser RH, Owens GK, Koch WJ, Dumont AS: Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. PLoS One. 2013, 8: e71954-10.1371/journal.pone.0071954.PubMedCentralCrossRefPubMed
24.
25.
go back to reference Chalouhi N, Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Koch WJ, Dumont AS: Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm. 2013, 2012: 271582. Chalouhi N, Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Koch WJ, Dumont AS: Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm. 2013, 2012: 271582.
26.
go back to reference Wright JL, Tai H, Wang R, Wang X, Churg A: Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Am J Physiol Lung Cell Mol Physiol. 2007, 292: L125-L133.CrossRefPubMed Wright JL, Tai H, Wang R, Wang X, Churg A: Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Am J Physiol Lung Cell Mol Physiol. 2007, 292: L125-L133.CrossRefPubMed
27.
go back to reference Fan J, Li X, Zhong L, Hao T, Di J, Liu F, Zhao HH, Bai SL: MCP-1, ICAM-1 and VCAM-1 are present in early aneurysmal dilatation in experimental rats. Folia Histochem Cytobiol. 2010, 48: 455-461.CrossRefPubMed Fan J, Li X, Zhong L, Hao T, Di J, Liu F, Zhao HH, Bai SL: MCP-1, ICAM-1 and VCAM-1 are present in early aneurysmal dilatation in experimental rats. Folia Histochem Cytobiol. 2010, 48: 455-461.CrossRefPubMed
28.
go back to reference Moriwaki T, Takagi Y, Sadamasa N, Aoki T, Nozaki K, Hashimoto N: Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke. 2006, 37: 900-905. 10.1161/01.STR.0000204028.39783.d9.CrossRefPubMed Moriwaki T, Takagi Y, Sadamasa N, Aoki T, Nozaki K, Hashimoto N: Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke. 2006, 37: 900-905. 10.1161/01.STR.0000204028.39783.d9.CrossRefPubMed
29.
go back to reference Rosenberg GA: Matrix metalloproteinases in neuroinflammation. Glia. 2002, 39: 279-291. 10.1002/glia.10108.CrossRefPubMed Rosenberg GA: Matrix metalloproteinases in neuroinflammation. Glia. 2002, 39: 279-291. 10.1002/glia.10108.CrossRefPubMed
30.
go back to reference Kim SC, Singh M, Huang J, Prestigiacomo CJ, Winfree CJ, Solomon RA, Connolly ES: Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery. 1997, 41: 642-666. discussion 646–647PubMed Kim SC, Singh M, Huang J, Prestigiacomo CJ, Winfree CJ, Solomon RA, Connolly ES: Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery. 1997, 41: 642-666. discussion 646–647PubMed
31.
go back to reference Nakajima N, Nagahiro S, Sano T, Satomi J, Satoh K: Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls. Acta Neuropathol. 2000, 100: 475-480. 10.1007/s004010000220.CrossRefPubMed Nakajima N, Nagahiro S, Sano T, Satomi J, Satoh K: Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls. Acta Neuropathol. 2000, 100: 475-480. 10.1007/s004010000220.CrossRefPubMed
32.
go back to reference Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ. 2003, 10: 45-65. 10.1038/sj.cdd.4401189.CrossRefPubMed Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ. 2003, 10: 45-65. 10.1038/sj.cdd.4401189.CrossRefPubMed
33.
go back to reference Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N: Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke. 2007, 38: 162-169. 10.1161/01.STR.0000252129.18605.c8.CrossRefPubMed Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N: Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke. 2007, 38: 162-169. 10.1161/01.STR.0000252129.18605.c8.CrossRefPubMed
34.
go back to reference Kondo S, Hashimoto N, Kikuchi H, Hazama F, Nagata I, Kataoka H: Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke. 1998, 29: 181-188. 10.1161/01.STR.29.1.181. discussion 189CrossRefPubMed Kondo S, Hashimoto N, Kikuchi H, Hazama F, Nagata I, Kataoka H: Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke. 1998, 29: 181-188. 10.1161/01.STR.29.1.181. discussion 189CrossRefPubMed
Metadata
Title
Critical role of TNF-α in cerebral aneurysm formation and progression to rupture
Authors
Robert M Starke
Nohra Chalouhi
Pascal M Jabbour
Stavropoula I Tjoumakaris
L Fernando Gonzalez
Robert H Rosenwasser
Kosuke Wada
Kenji Shimada
David M Hasan
Nigel H Greig
Gary K Owens
Aaron S Dumont
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2014
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-11-77

Other articles of this Issue 1/2014

Journal of Neuroinflammation 1/2014 Go to the issue